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Eligibility determinationPrevious research on standardization of eligibility criteria and its feasibility has traditionally been con-
ducted on clinical trial protocols from ClinicalTrials.gov (CT). The portability and use of such standardi-
zation for full-text industry-standard protocols has not been studied in-depth. Towards this end, in this
study we ﬁrst compare the representation characteristics and textual complexity of a set of Pﬁzer’s inter-
nal full-text protocols to their corresponding entries in CT. Next, we identify clusters of similar criteria
sentences from both full-text and CT protocols and outline methods for standardized representation of
eligibility criteria. We also study the distribution of eligibility criteria in full-text and CT protocols with
respect to pre-deﬁned semantic classes used for eligibility criteria classiﬁcation. We ﬁnd that in compar-
ison to full-text protocols, CT protocols are not only more condensed but also convey less information.
We also ﬁnd no correlation between the variations in word-counts of the ClinicalTrials.gov and full-text
protocols. While we identify 65 and 103 clusters of inclusion and exclusion criteria from full text proto-
cols, our methods found only 36 and 63 corresponding clusters from CT protocols. For both the full-text
and CT protocols we are able to identify ‘templates’ for standardized representations with full-text stan-
dardization being more challenging of the two. In our exploration of the semantic class distributions we
ﬁnd that the majority of the inclusion criteria from both full-text and CT protocols belong to the semantic
class ‘‘Diagnostic and Lab Results’’ while ‘‘Disease, Sign or Symptom’’ forms the majority for exclusion cri-
teria. Overall, we show that developing a template set of eligibility criteria for clinical trials, speciﬁcally in
their full-text form, is feasible and could lead to more efﬁcient clinical trial protocol design.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Clinical trials are an intrinsic part of the medical research and
drug development process of most pharmaceutical and biotechnol-
ogy companies. Policy makers and governmental organizations are
also naturally interested in evaluating the efﬁcacy, accuracy and
safety of drugs trials that could potentially affect millions of people
around the world. Eligibility criteria in clinical trials are a set of
requirements that a patient or participant must meet to be eligible
for inclusion in a study. From the perspective of a study sponsor,
these requirements ensure that all participants in a cohort satisfy
some general criteria and thus give a higher conﬁdence in predict-
ing possible outcome of an intervention.
Eligibility criteria are usually expressed in human-readable
free-text which is easily comprehensible to patient, public and
researchers alike. However this form of representation of eligibilitycriteria makes it challenging for computable and standardized rep-
resentation. Currently, there are no data or terminology standards
for representing or authoring eligibility criteria in a standard for-
mat [1–3]. Given the plethora of applications of eligibility criteria,
ranging from criteria reuse to patient matching from Electronic
Medical Records (EMR) [4,5] it is of great importance to address
the problem of computable knowledge-based representation for
eligibility criteria. The primary motivation of our study is to deter-
mine the feasibility of creating a set of standard representations of
eligibility criteria that would be applicable to a broad set of clinical
trials. Uniformly represented eligibility criteria can facilitate the
process of identiﬁcation and merging of similar patient popula-
tions across studies for the purpose of patient recruitment. Conse-
quently, this can reduce not only the time spent in performing
trials that have already been conducted under similar conditions
but can also help in reducing the expenses associated with partic-
ipant recruitment substantially. Secondary outcomes of interest
would be easier encoding of eligibility criteria to ﬁnd patients via
EMRs, faster and accurate authoring of eligibility criteria, and high-
er quality protocols. For example, a standardized representation of
an eligibility criterion could be linked to a speciﬁc, standard set of
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across EMR systems.
We begin by comparing the textual and characteristic differ-
ences of industry-standard full-text protocols to corresponding
protocols from ClinicalTrials.gov (CT) [6], a registry of clinical stud-
ies from around the world. We then explore methods for deriving
computable and standardized representation of eligibility criteria,
in the form of templates, from a set of full-text and CT protocols
used in Pﬁzer’s pain medication-related studies.
Our contributions in this paper are two-fold. First, we explore
the nature of representation of eligibility criteria from industry-
standard full-text protocols and compare their characteristics to
corresponding CT eligibility criteria. Second, we propose a novel
method for standardized representation of eligibility criteria (using
sentence similarity and clustering strategies) in the form of ‘‘tem-
plates’’. To the best of our knowledge, this is the ﬁrst study in the
domain of standardized representation of eligibility criteria that
deals with in-depth analysis of eligibility criteria characteristics
in their full-text form. Most related research deal with consider-
ably simpler and concise eligibility criteria from CT.
2. Related research
Computable clinical trial protocols and corresponding eligibility
criteria representations have been studied extensively in the past
two decades. Studies have been conducted to identify a set of com-
mon data elements that can be used for developing standard proto-
col representation [7]. There have been attempts to use natural
language processing for parsing eligibility criteria statements to ex-
tract generic query patterns for eligibility criteria representation
[8,9]. Research has also been focused on the identiﬁcation of Uniﬁed
Medical Language System (UMLS) - based [10] semantic classes for
criteria statements [11,12]. The complexity of eligibility criteria
representation has also been studied quantitatively with signiﬁcant
proportion of criteria being judged semantically complex [13].
There have been extensive studies in computer-based and for-
mal eligibility criteria knowledge representations. A CDISC-spon-
sored project called ASPIRE [14] aims to provide formal
representation of a core set of eligibility criteria and also provides
a set of data elements which can be used for searching and ﬁltering
protocols. The Eligibility Rule Grammar and Ontology (ERGO) [15],
uses an informationmodel, composed of noun phrases, expressions
and criteria, to provide a general syntax for representing eligibility
criteria. The EliXR system [3] provides a semi-automated data-dri-
ven approach for semantic representation of eligibility criteria. It
uses an integrated semantic processing framework based on UMLS
for eliciting semantic role labels that can be used for annotating
eligibility criteria. The Standards-Based Active Guideline Environ-
ment (SAGE) [16] provides a set of structured and standard termi-
nologies for encoding computable guidelines into structured
templates. The Clinical Research Filtered Query (CRFQ) Project
[17] provides a standardization of criteria using various semantic
parameters like demographic data, disease data, etc. The use cases
of these systems vary from ﬁltering trials satisfying particular con-
ditions to the identiﬁcation of patients for a protocol.
Previous research [18] has demonstrated the beneﬁt of using a
set of disease-categorized protocols for designing efﬁcient clinical
trial authoring tools. Signiﬁcant research has also been conducted
in developing decision support systems for clinical trials. Expert
systems like the protocol inspection and critiquing tool (PICASSO)
[19] support critiquing of clinical trial protocols and can be used to
standardize new protocols. Knowledge-based decision support sys-
tems like Design-a-Trial (DaT) [20] help efﬁcient creation of rigor-
ous protocols documents for designed trials. The ontology-based
system, TrialWiz, [21] designed to alleviate the complexity of the
protocol encoding process can be used for easy authoring of clinicaltrial protocols. More advanced authoring tools that facilitate col-
laboration of protocol authors from different backgrounds have
also been proposed [22]. Other than these applications, several
open-source (e.g. OpenClinica [23]) and proprietary (e.g. Cytel
[24], Medidata [25]) software have also been designed for assisting
or automating the clinical trial protocol design process.
Although several of the above mentioned tools and applications
have been developed for standardized and computable representa-
tion of eligibility criteria few can deal with the complexity of eligi-
bility criteria as presented in full-text protocols. Most of these
applications [13–15] are either semi-automated or designed using
CT protocols. They still require intense manual involvement and
lack ﬂexibility for accommodating complex eligibility criteria from
full-text protocols. While these tools may be capable of generating
computable and knowledge-based representation of basic eligibil-
ity criteria, their utility, usability and adoptability to eligibility cri-
teria from industry-standard protocols have not been tested
rigorously. We also note that the use of automated tools for criteria
standardization has very limited uptake in the industry as few of
them cater to the complexities of full-text protocols. Therefore,
we perform a detailed comparison of eligibility criteria representa-
tion from CT and Pﬁzer’s clinical trial protocols and propose a novel
method which can be used for industry-standard standardization.
In contrast to several of the above mentioned tools, our tem-
plate-based standardization approach caters to criteria reuse,
which is a major objective in most pharmaceutical companies [26].3. Materials and methods
In this paper we present an analysis of eligibility criteria from
full-text and CT protocols across 3 dimensions. First, we compare
the representation characteristics and textual complexity of eligi-
bility criteria from full-text and their corresponding CT protocols.
Second, we perform a semantic class-based comparison of these
two forms of eligibility criteria representation. Finally, we generate
templates based on a novel method for industry-standard full-text
protocol standardization.
3.1. Data
We selected a set of 32 full-text clinical trial protocols in the do-
main of Pﬁzer’s pain-related drug research designed between the
years 2002 and 2009. In a majority of these studies, the primary
objective was to evaluate the efﬁcacy, safety or tolerability of the
drugs in various patient groups under different conditions for pains
related to diabetic neuropathy, total-knee arthroplasty, ﬁbromyal-
gia, osteoarthritis, etc. We used the study identiﬁer of the full-text
protocols to retrieve the 32 corresponding XML-formatted proto-
cols from CT, which currently houses over 120,000 clinical trial
protocols [6]. Organizations that sponsor or conduct clinical trials
are required to submit study information to a clinical trial registry
like CT if they plan to publish the ﬁndings in a major journal. We
wanted to compare eligibility criteria from Pﬁzer’s full-text clinical
trial protocols with the corresponding protocols retrieved from CT
to assess the characteristic differences between the representation
of CT and full-text. In essence, this will inform us of the complexity
and processing overhead in terms of computational methods used
for various studies on eligibility criteria (such as standardized
representation).
3.2. Comparison of representation characteristics and textual
complexity of full-text eligibility criteria vs. CT eligibility criteria
We ﬁrst compared the representation characteristics of the eli-
gibility statements of the full-text and CT protocols from our data-
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Criteria’’ sections of the full-text protocols with the corresponding
study protocols downloaded from CT. We use cumulative and aver-
age word counts and sentence counts for this purpose.
3.3. Standardization of eligibility criteria
We analyze the eligibility criteria representation across 32 full-
text protocols and their corresponding CT protocols, representing a
cross-section of Pﬁzer protocols in the pain therapeutic area. Our
goal here is to develop a sentence-similarity based approach to
identify groups of similar sentences having similar conceptual
properties but different textual representation across various pro-
tocols. Fig. 1 shows the underlying algorithm for this process.
3.3.1. Preprocessing
In this step we converted all the full-text PDF ﬁles to their cor-
responding text format using standard conversion tools. The con-
verted text ﬁles were veriﬁed to not contain Optical Character
Recognition (OCR) errors. These ﬁles were then parsed using regu-
lar expressions to identify the ‘‘Eligibility Criteria’’ sections. Each
‘‘Eligibility Criteria’’ section was further segmented into Inclusion
and Exclusion Criteria for further processing. Similar pre-process-
ing was also performed on the XML ﬁles from CT.
3.3.2. Sentence splitting
The Inclusion and Exclusion criteria sections for both the full-
text and CT protocols generally comprise of related but disjoint
sentences grouped together. These were segmented into sentences
using a maximum entropy-based sentence boundary detector,
MxTerminator [27]. However, since some criteria sections (appear-
ing as bulleted lists) did not end with periods, we had to follow
additional steps to split such sections. On the other hand, sepa-
rated sentences which were in fact coherent and represented
continuing ideas had to be coupled together as a single unit.
3.3.3. MetaMap similarity
In this step we processed the individual sentences obtained
from the previous step using the National Library of Medicine’s
MetaMap program [28]. MetaMap can identify coherent words
and phrases from a particular sentence and map them to Uniﬁed
Medical Language System (UMLS) metathesaurus concepts. We
then compared each sentence with every other sentence in the
pool of criteria sentences and identiﬁed the ones where all the
UMLS concept identiﬁers (CUI) matched exactly. This process
helped in ironing out the minor differences in similar sentences
with identical concepts but different representations. Word to
word matching of sentences was not employed here because even
the subtle variability in spelling or sentence structure could not be
handled by using that method. The output of this step is a set ofFig. 1. Flowchart of eligibility criteria processing for sentence clustering and
semantic classiﬁcation.sentences that are identical to one or more sentences. Box 1 shows
the advantage of using MetaMap similarity over simple word to
word matching based identical sentence detection. For Sentence
1, we can see that the versions 1 and 2 represent the same criteria,
except with different values for a speciﬁc test (Creatinine clear-
ance). For Sentence 2, ‘less than’ has different representation in
the two versions. Also the screening values for platelet count,
which are identical in essence, are represented in different format
in the two versions. Using concept matching of MetaMap we can
overcome these minor structural, grammatical or numeral varia-
tions to elicit the fundamental similarities between sentences.
The importance of such abstraction has also been explained previ-
ously. The set of remaining sentences, classiﬁed as non-identical,
are processed in the next step.
3.3.4. Cosine similarity
In this step we identify similar sentences from the set of non-
identical sentences using cosine similarity [29]. While cosine sim-
ilarity has been used extensively for clustering similar sentences
and documents [30–33], it has not been explored in the domain
of eligibility criteria standardization. For this purpose we create
an index of all non-identical sentences using the SMART informa-
tion retrieval system [34]. Each sentence is treated as an individual
record and cosine similarity is calculated with every other sen-
tence in the pool. SMART, based on a vector space model, repre-
sents each sentence as a vector of words with different weights
associated with each term of a sentence. Standard preprocessing
steps like stemming and stopword removal were executed before
calculating the cosine similarity of sentences. The cosine measure
of similarity for length-normalized pair of vectors q and di, where
q represents a query and di represents a document set,
is calculated as follows:
simðq;diÞ ¼
Pt
j¼1wqjwijﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPt
j¼1w
2
qj
q

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPt
j¼1w
2
ij
q
Here wqj and wij are the term weights for the vectors q and di
represented as t-dimensional vectors. In our case, query q is a given
criteria statement which is compared to the document set di repre-
sented as a pool of the criteria statements (not including q).
In SMART we select the standard atc term weighting scheme.
Here a represents the term frequency component and is calculated
as an augmented term frequency, t represents the collection fre-
quency component and is calculated as the inverse document fre-
quency, while c represents the normalization component
calculated as the cosine normalization. A set of similar sentences
can be, in essence, treated as a coherent cluster.
3.3.5. Sentence clustering
In this step we select sentences which are similar to a particular
sentence. A threshold similarity score of 0.5 (selected on an empir-
ical basis) is used for selecting similar sentences. For each sentenceBox 1
Example of MetaMap similarity.
Version 1 Version 2
Sentence 1 Creatinine clearance
<30 mL/min (estimated
from serum creatinine,
body weight, age, and
sex using the Cockcroft
and Gault equation)
Creatinine clearance
<60 mL/min (estimated
from serum creatinine,
body weight, age, and
sex using the
Cockcroft–Gault
equation)
Sentence 2 Platelet count less than
100,000
Platelet count
<100  103 mm3
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cluded in a particular cluster is eliminated for inclusion in any
other cluster. A higher similarity score threshold gives fewer sim-
ilar sentences and hence greater number of clusters while a lower
similarity score gives more similar sentences clustered into fewer
groups. Since an absolute threshold scores does not always result
in perfect sentence clusters, we used a post-processing step where
each cluster of similar sentences was manually veriﬁed to not con-
tain unrelated sentences. Further, clusters were merged based on
overlapping or associated ideas. Overall our clustering method
with ﬁxed clustering threshold performed well and only 10-20%
of the sentences from the inclusion and exclusion criteria had to
be manually reassigned for full-text or CT criteria. We found this
approach and threshold scores reasonable for our study. Given
the complexity of the eligibility criteria sentences from our full-
text protocols we did not ﬁnd any automated tools or applications
appropriate for standardization. If a particular sentence does not
have any similar sentences (based on the criteria deﬁned above),
we consider that sentence to be the only entity in that cluster. Such
sentences are assumed to form singleton clusters. A sample clus-
tering of sentences is shown in Fig. 3. In this example, sentences
1, 2 and 4 are detected as similar sentences in one cluster while
sentences 3 and 5 are detected as similar sentences in a different
cluster. However based on the criteria deﬁned above, we merged
these clusters together in the post-processing step. This gave us
ﬁve sentences which have different textual characteristics and rep-
resentation but linked by the same underlying concept. Thus the
sentence clustering step helped us identify the variability in repre-
sentation of eligibility criteria. This forms the basis of our stan-
dardization approach for eligibility criteria which preserves the
underlying properties of each sentence cluster while providing
an abstraction of the ﬁner details. For a cluster of sentences, we
ﬁrst identify the key concepts (e.g. diseases or symptoms, patho-
logical tests, therapies or surgeries, etc.) represented in the set of
inclusion and exclusion criteria. We then identify the range of val-
ues (if any) that correspond to these concepts and represent those
with a variable while preserving the units associated with such
values. These elements are then manually structured in the form
of a template.3.3.6. Sentence classiﬁcation
The identical sentences and the sentence clusters obtained from
the previous steps were manually labeled using the semantic clas-
siﬁcation of clinical research eligibility criteria identiﬁed in [11,12].
It is important to note here that the semantic classes used for label-
ing the sentence clusters were derived only from [11,12] and no
extraneous semantic classes were introduced for sentence classiﬁ-
cation. A total of 27 semantic classes under 6 topic groups were
used as reference. For example, the topic group ‘‘demographics’’Box 2
Eligibility criteria statements from CT and full-text protocols.
# CT protocol Ful
I1 Adults with type 1 or 2 diabetes Dia
lev
30
acc
I2 Patients must have pain in their lower legs or feet due to
painful diabetic neuropathy that has lasted for at least
3 months
Dia
pol
red
dia
E1 Patients must not be in poor or unstable health Oth
lab
par
inte
the
thiscontains six semantic classes, namely, address, age, literacy, gen-
der, ethnicity, and special patient characteristics (for details on
the other topic groups refer to [11,12]).4. Results
4.1. Comparison of representation characteristics of eligibility criteria
from full-text vs. CT
We compared the representation characteristics of the eligibil-
ity statements from the full-text and CT protocols from our dataset.
We found that the criteria statements from the CT protocols are
more concise than the corresponding statements from the full-text.
The CT protocol statements generally provide a high level abstrac-
tion of the detailed representation of the full-text protocols. In
Box 2, we compare the statements of CT protocols with matching
statements from full-text protocols.
Statements I1, I2 and E1 represent the two inclusion criteria and
the only exclusion criteria for one of the CT protocols and corre-
sponding statements from the full-text protocol. Statements I1
and I2 of the CT protocol are both simpliﬁed versions of their cor-
responding full-text protocol statements. Though these statements
contain the gist of the criteria under discussion, the CT eligibility
criteria are an abstraction of the details provided in the full-text.
Similarly, the statement E1 of the CT protocol conveys the same
idea as the full-text without elaborating on the details. However,
we note that several critical eligibility statements are not included
in the CT protocols. For example, inclusion criteria (such as ‘‘A
score of P40 mm on the visual analog scale (VAS) of the Short-
Form McGill Pain Questionnaire (SF-MPQ) at baseline (V1 and
V3)’’) or exclusion criteria statements (such as ‘‘Have had a malig-
nancy other than basal cell carcinoma within the past 2 years’’)
that provide ﬁner details for patient selection are omitted in the
CT protocols. While explicit representation of these details is not
a mandatory requirement for CT postings, research on computa-
tional methods for studying eligibility criteria generally gloss over
these inherent complexities [4]. In particular, full-text protocols
would provide a more challenging setting for text mining or natu-
ral language processing tasks compared to the CT protocols.
4.2. Comparison of textual complexity of eligibility criteria from full-
text vs. CT
Overall, we found that the eligibility criteria sections of study
protocols from CT are considerably shorter compared to the corre-
sponding full-text version. The number of inclusion and exclusion
criteria in a typical full-text protocol is almost 5 times greater than
the corresponding CT protocol (the total number of inclusion and
exclusion criteria sentences from full-text protocols are 374 andl-text protocol
gnosis of type 1 or 2 diabetes mellitus with current hemoglobin A1C
els of 611% and on a stable antidiabetic medication regimen for the
days prior to randomization. A sliding scale of insulin therapy is
eptable
gnosis of painful, diabetic distal symmetrical sensorimotor
yneuropathy for at least 3 months; diagnosis includes absent or
uced deep tendon reﬂexes at both ankles (refer to Appendix 1 for
gnostic criteria)
er severe acute or chronic medical or psychiatric condition or
oratory abnormality that may increase the risk associated with trial
ticipation or investigational product administration or may
rfere with the interpretation of trial results and, in the judgment of
investigator, would make the subject inappropriate for entry into
trial
Table 1
Cumulative word count in inclusion and exclusion criteria of CT vs. Full-text
protocols and percentage of total words.
ClinicalTrials.gov 2107 (44%) 2679 (56%)
Full-text 9413 (30%) 22,033 (70%)
Table 2
Distribution of identical and non-identical sentences for inclusion and exclusion
criteria.
Inclusion criteria (full-
text/CT)
Exclusion criteria (full-
text/CT)
Total 374/100 712/169
Identical sentences 166 (44%)/30 (30%) 61 (8%)/38 (22.5%)
Non-identical
sentences
208 (56%)/70 (30%) 651 (92%)/131 (77.5%)
Table 3
Number of clusters for each semantic class.
Semantic class # of Inclusion clusters
(full-text/CT)
# of Exclusion clusters
(full-text/CT)
Age/gender 1/1 –/–
Ethnicity 1/1 –/–
Special patient
characteristic
1/1 –/–
Diagnostic and lab
results
23/13 19/9
Disease, sign or
symptom
15/9 26/22
Neoplastic status –/– 2/–
Pregnancy 1/1 2/1
Consent 2/1 –/–
Capacity 1/– 1/–
Enrollment in other
studies
–/– 6/1
Preference 2/– 1/1
Compliance with the
protocol
2/1 1/1
Pharma substance or
drugs
9/3 25/16
Therapy or surgery 5/3 12/9
Addictive behavior 1/1 6/2
Diet –/– 2/1
Bedtime 1/1 –/–
Total clusters 65/36 103/63
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the average word count for the CT eligibility criteria sections was
150 words compared to 982 words of full-text protocols. The low-
est word count for CT protocols was 14 while the highest was 737.
For the full-text protocols the lowest word count was 425 while
the highest was 2007.
From Table 1 we can see that even though exclusion criteria in
CT protocols have more words than the corresponding inclusion
criteria, the difference in their word count (12%) is lesser compared
to the corresponding full-text protocols (40%). It is also important
to note that the inclusion and exclusion criteria from CT protocols
encompass only a small fraction (22% and 12%, respectively) of the
actual textual content of the full-text protocols.
Fig. 2 presents the word count of each full-text protocol along
with the word-count of corresponding CT protocols. The distribu-
tion of word count for the inclusion and exclusion criteria are also
shown within each stacked bar. The chart has been sorted by the
total word count of full-text protocols from left to right. Interest-
ingly, we see no overall correlation between the word count of
full-text protocols and CT protocols. Sparing a few cases (e.g. Pro-
tocol #1), higher word count of full-text protocols does not ensure
high word count of corresponding CT protocols. It is important to
note here that CT protocols, intended for recruitment, and the
full-text criteria, intended for actual enrollment, have different
audiences and purposes. Hence there might not be any apparent
correlation between the authoring styles or word-counts of these
two types of representations.
Following the methods outlined in Section 3.3.3, we studied the
distribution of identical and non-identical sentences from the
inclusion and exclusion criteria for full-text and CT protocols
respectively (Table 2). We note that the percentage of identicalFig. 2. Per-document word count of full-text vs. CT protocols. (X-axis: the indivisentences in the inclusion criteria for full-text protocols (44%)
and CT protocols (30%) is signiﬁcantly more than identical
sentences in the exclusion criteria (8% and 22.5%). The primarydual numbered protocols; Y-axis: the cumulative word count of protocols).
Table 4
Classiﬁcation of sentences w.r.t. various semantic classes with topic groups in parenthesis (1 – Demographics, 2 – Diagnostic or Lab Tests, 3 – Health Status, 4 – Ethical
Consideration, 5 – Treatment or Healthcare, and 6 – Lifestyle Choice).
Semantic class % of Inclusion criteria
(full-text/CT)
% of Exclusion criteria
(full-text/CT)
Example criterion
(1) Age/gender 9.1%/10% –/– Male or female aged 18 or older
(1) Ethnicity 1.1%/1% –/– Subjects must have self-reported African American descent.
(1) Special patient characteristic 0.3%/5% –/– Outpatient
(2) Diagnostic and lab results 34.2%/32% 18.4%/8.8% Score of P40 mm on the 100 mm Visual Analogue Scale (VAS) of the
Short Form McGill Pain Questionnaire (SF-MPQ) at screening (Visit 1)
and at baseline (Visit 2)
(3) Disease, sign or symptom 7.8%/14% 43.4%/47.9% Subjects with a relevant neurological disease at Screening with which
their urinary symptoms may be associated (e.g. multiple sclerosis,
Parkinson’s disease, spinal cord injury, spinal cord lesion, familial
neuropathy, spina biﬁda or diabetic cystopathy)
(3) Neoplastic status –/– 1.4%/– Subjects treated for cancer (ie, surgery, chemotherapy, radiation
therapy, etc.) and/or in remission for any cancer other than basal cell
carcinoma or squamous cell carcinoma within 2 years of screening
(3) Pregnancy 13.9%/9% 1.8%/3.5% Female patients must be non-pregnant and non-lactating, and be
either postmenopausal, surgically sterilized, or using an appropriate
method of contraception (including barrier or hormonal method)
(4) Consent 14.4%/5% –/– Evidence of a personally signed and dated informed consent document
indicating that the subject (or a legally acceptable representative) has
been informed of all pertinent aspects of the trial
(4) Capacity 1.9%/– 0.4%/– The patient is willing to take ‘‘nothing by mouth’’ except trial
medication during the 2 h while at the site and for the entire 24-h
period following trial drug administration (e.g. no smoking, candy,
lozenges, chewing gum)
(4) Enrollment in other studies –/– 6.3%/0.5% Concurrent or previous participation in another clinical trial within
30 days prior to screening
(4) Preference 4%/3% 1.8%/0.5% The patient is willing to remain at the trial center for 2 h after receiving
the ﬁrst dose of trial medication
(4) Compliance with the protocol 4.8%/3% 1.3%/0.5% Subjects who are willing and able to comply with scheduled visits,
treatment plan, laboratory tests, the self-completion of study
questionnaires and symptom diaries, and other trial procedures
(5) Pharma Substance or Drugs 6.4%/10% 15.7%/23.6% The patient has used any analgesic/antipyretic within 1 dosing interval
preceding administration of the ﬁrst dose of trial medication
(5) Therapy or Surgery 1.3%/3% 4.9%/10% Subjects at Screening who intend to start a bladder training program,
electrostimulation therapy e.g. Transcutaneous Electrical Nerve
Stimulation (TENS), or physiotherapy regimen during the study
(6) Addictive behavior 0.3%/2% 4.1%/3.5% History of regular alcohol consumption exceeding 7 drinks/week for
females or 1 drinks/week for males (1 drink = 5 ounces (150 mL) of
wine or 1.ounces (360 mL) of beer or 1.5 ounces (45 mL) of hard liquor)
within 6 months of Screening
(6) Diet –/– 0.4%/0.5% Unwillingness to refrain from consumption of grapefruit or grapefruit
juice from 7 days prior to the ﬁrst dose of study medication until
completion of the study
(6) Bedtime 0.5%/3% –/– Maintain a normal daytime-awake, nighttime–asleep schedule,
including approximately 6.5–8.5 h each night in bed, and less than 3 h
variation in night-to-night bedtime for the past month prior to
screening (Visit 1)
2 The classes age and gender were grouped together based on their co-occurrence
in the full-text criteria statements
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of criteria in the exclusion section. In our dataset we noted that
inclusion criteria from full-text or CT follow a more standard ap-
proach in deﬁning screening conditions. For example, criteria
statements on demographic information (age, gender, ethnicity,
etc.) or ethical considerations (consent or compliance with study)
have the least variability in the inclusion criteria.
4.3. Semantic class-based sentence clustering from full-text and CT
criteria
Table 3 shows the total number of clusters identiﬁed for the
inclusion and exclusion criteria sections as well as the distribution
of clusters for each semantic class for the full-text and CT protocols
respectively. Semantic classes such as ‘‘Capacity’’ or ‘‘Ethnicity’’
form singleton clusters for inclusion criteria for both full-text
and CT protocols while ‘‘Preference’’ and ‘‘Compliance with proto-
col’’ form singleton clusters for both types of protocols. For inclu-
sion criteria, the semantic class ‘‘Diagnostic and Lab Results’’
contains the maximum number of clusters for both full-text and
CT protocols. In case of exclusion criteria, ‘‘Disease, Sign or Symp-tom’’ and ‘‘Pharma Substance and Drugs’’ form majority of the
clusters.
Table 4 shows the classiﬁcation of inclusion and exclusion crite-
ria from Pﬁzer’s full-text protocols and CT protocols based on the
semantic classes. The percentage of criteria statements belonging
to each semantic class is also shown in Table 4. We note that some
semantic classes such as age/sex2, ethnicity or neoplastic status are
present in only one type of criteria statements. It is also interesting
to note that most of the sentences in the inclusion criteria belong to
the ‘‘Diagnostic and Lab Results’’ category while ‘‘Disease, Sign or
Symptom’’ is the most dominant class for exclusion criteria. The dis-
tribution of different classes for the inclusion and exclusion criteria
gives us an overall idea of the nature of statements present in these
sections and shows the contrast in the emphasis of these two
sections.
Fig. 3. Example of similar sentences and template representation. Sentences
number 1–5 represent a cluster of sentences tied by the same underlying concept
which is represented in the form of a template in the grayed box in the centre.
S. Bhattacharya, M.N. Cantor / Journal of Biomedical Informatics 46 (2013) 805–813 8114.4. Template-based representation of eligibility sentences from full-
text criteria
In Fig. 3 we consider a set of ﬁve similar sentences (numbered
1–5) having distinct properties in terms of textual and numeral
representation. However all of them share the same underlying
concept i.e. a threshold value for alanine aminotransferase (ALT)
or aspartate aminotransferase (AST) for eligibility in a particular
study. This can be abstracted in the form of a central idea around
which the different representations are formed. In our example,
this central idea (referred to as ‘‘template’’) is ‘‘ALT or AST clinical
laboratory values > N times the ULN’’ where N is a variable. Such
templates are prototypical of all the sentences in the cluster. It is
important to note that this template identiﬁcation is based on heu-
ristics and can be expressed in various ways as long as it represents
the core idea of the sentence cluster. Following a similar strategy
we can form a template for any cluster shown in Table 3. Sample
template sentences from the ‘‘Disease, Sign or Symptom’’ category
can be found in Table 5. In this table, we show the variations in
terms of the number of sentences belonging to various clusters
and their possible templates. The categories of diseases or symp-
toms they belong to are also shown. Of note, criteria often contain
concrete examples such as those delineated in the ‘‘Disease, Sign or
Symptom’’ entry in Table 4 above.Table 5
Potential templates for selected ‘‘disease, sign or symptom’’ exclusion criteria.
Category Variations
Malignancy 15
Infectious Disease 12
Psychiatric 17
Cardiac 31
Gastrointestinal 29The outcome of this template-based representation process is a
set of prototypes that provide generalization of the criteria state-
ments across protocols while preserving the core concepts. Thus
any eligibility criteria can be expressed with this set of predeﬁned
templates. In essence, these templates will potentially reduce the
effort of a protocol designer in formulating criteria. However it is
important to note here that the templates generated from the CT
protocols do not match in number or complexity to those from
the full-text protocols. Hence repurposing of CT templates for
full-text is not feasible without loss of information. Once we have
identiﬁed a set of criteria templates for a given domain (e.g. pain-
related drugs) we can use such templates to design other protocols
in the same domain. Identiﬁcation of templates in various domains
and their combination should allow us to abstract out commonly
occurring templates that generally appear in most eligibility crite-
ria (e.g. demographics, consent, etc.). We can also identify tem-
plates unique to particular domains. This type of regularity in
representation will pave way for standardized and computable eli-
gibility criteria. We also noted in Table 2 that only 8% and 22.5% of
inclusion criteria in the full-text and CT protocols are identical
across various studies. Identiﬁcation of clusters and thereby tem-
plate formation can provide signiﬁcant beneﬁts for standardized
representation in such cases with greater variability. Use cases of
this template-based representation can be found in research in
query-based information retrieval or information extraction from
full-text protocols that cater to eligibility determination. Other
use cases can be found in the areas of natural language processing,
expression language standards, criteria designing and criteria
authoring mechanisms.5. Discussion
The comparison between CT and the full-text criteria shows the
expected higher complexity in the actual trial protocols. The num-
ber of inclusion and exclusion criteria in the full-text protocols is
several times greater than the corresponding CT protocols. Also
each criterion from the full-text protocols is generally more elabo-
rate and contains additional information that supplements the core
information which is otherwise not presented in CT protocols. This
is not surprising since CT’s purpose is mainly for general and refer-
ence information, while the full-text protocols are for actually run-
ning the trial. The impact of this ﬁnding for analyzing clinical trials,
however, is that systems built over data from CT may not be sufﬁ-
ciently robust for analyzing full-text protocols. This is one of the
primary reasons for low uptake of standardization tools, built over
CT eligibility criteria, in the industry. We believe that pointing out
the differences in representation of full-text vs. CT criteria will helpSuggested template
Active malignancy of any type or history of a malignancy within X
years (with the exception of subjects with a history of treated basal cell
carcinoma)
History of chronic hepatitis B or C, acute hepatitis A, B or C within the
past X months, or HIV infection
History, diagnosis, signs or symptoms of any clinically signiﬁcant
psychiatric disorder that would, in the investigators opinion, preclude
study participation or compliance with protocol mandated procedures
Subject has any history of any clinically signiﬁcant cardiovascular
disease; or any history or evidence on physical examination of clinical
symptoms suggestive of cardiac disease
Has active GI disease (e.g. inﬂammatory bowel disease), or a history of
GI ulcers or bleeding that in the opinion of the investigator would
interfere with the absorption of study medication
812 S. Bhattacharya, M.N. Cantor / Journal of Biomedical Informatics 46 (2013) 805–813in delineating more robust systems for industry-standard criteria
standardization in the future.
As evidenced in the examples in Table 5, it is feasible to create a
set of standard templates for commonly used eligibility criteria.
Though there will always be unique clusters in sets of criteria,
since each trial is looking to answer a unique question, ultimately
one could use this set to produce a bank of standardized criteria
(i.e. templates) that could be used across biomedical research.
The major beneﬁt would be simplifying authoring and quality con-
trol of protocols, as well as making the computational analysis of
the text of protocols more straightforward.
Our template-based standardization strategy likely beneﬁts
from the human expertise invested in reﬁning the clusters and
assigning templates to such clusters. Since accuracy of the tem-
plates was one of the most pivotal aspects for integration into
the industrial protocol generation workﬂow, we chose to manually
curate the templates.
A major contribution of this research is the set of templates that
can also be used in any protocol/criteria authoring tool. In future
research we plan to test the applicability of our templates as a
plug-in to an eClinical protocol designing and authoring tool.
In future work we also would like to explore better methods for
ﬁnding similar sentences. Though cosine similarity does fairly well
in identifying similar sentences based on word-vectors, it lacks the
capability of ﬁnding semantically similar words. For such ﬁne-
grained comparison we plan to use UMLS::Similarity[35] which
can determine semantic similarity between pairs of biomedical
concepts. The scalability of our clustering and template generation
approaches, especially, the semantic processing and knowledge
representation techniques employed in our methods requires fur-
ther investigation.6. Limitations
Our study is constrained by the limited availability of full-text
protocols (which is often governed by conﬁdentiality and privacy
policies of companies) from a particular sub-domain of clinical tri-
als (namely, pain-related drugs). While our semi-automated pro-
cess for clustering and template generation may not scale to
120,000 protocols [6] from diverse therapeutic areas they can at
least scale to the pain therapeutic area. As evidenced in our paper,
similarity of representation of eligibility criteria across these pro-
tocols points to the fact that we would have minor gains from add-
ing many more. We also note that while our dataset is mostly
company and therapeutic area speciﬁc, previous studies have
pointed to presence of several common design elements, including
inclusion and exclusion criteria representation, across protocols
[36,37]. Since industry protocols are all made to be reviewed by
the same audience (ultimately regulators like the FDA), this adds
an underlying structure and thus our assumption seems reason-
able that most industry protocols are structured similarly, and that
there is likely as much intra-company difference as there is inter-
company difference. In future research we would like to generate
protocols in other domains and perform cross-domain template
comparisons for gauging the generalizability of our ﬁndings. This
might give us an insight into the bigger picture of clinical trial de-
sign irrespective of the domain and can ideally help us in identify-
ing general templates versus domain-speciﬁc ones.
One of the limitations of our template based standardization is
the lack of ﬂexibility in representing temporal and certainty re-
lated constraints. We would like to explore tools for automatic
identiﬁcation of temporal and certainty expressions in future re-
search [38,39]. Also the use of MetaMap for semantic concept iden-
tiﬁcation may have certain limitations. Co-reference resolution and
conjugated representation for drug or disease terms are not han-dled by MetaMap [40]. We would like to explore the extent of such
issues in future research.
7. Conclusions
This research aimed at developing techniques for standardized
representation of eligibility criteria from industry-standard full-
text protocols. A comparison of full protocols vs. their representa-
tions in Clinicaltrials.gov supported the need for this approach,
since the full protocols were generally very complex. We proposed
a method built around using sentence similarity and clustering for
identifying groups of similar sentence. We then proposed a novel
method for template-based representation of eligibility criteria
that can lead to standardization of criteria statements. A combina-
tion of these templates potentially offers a standard and formal
representation of any eligibility criteria. Such template-based cri-
teria would be amenable for computational processing such as
information retrieval, information extraction, etc. Ideally, this pro-
cess should result in representation of computable criteria for eli-
gibility matching across different protocols. We hope that our
effort helps in eliciting differences between the commonly used
CT protocols and their full-text counterpart and thus pave the path
for building systems that can easily handle industry standard full-
text criteria.
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